Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
kinpeygo
stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, þarma bólgueyðandi / antiinfective lyfjum - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
tenutex húðfleyti 20 mg/g + 225 mg/g
bioglan ab - disulfiramum inn; benzylis benzoas - húðfleyti - 20 mg/g + 225 mg/g
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
heparin leo (heparin leo) stungulyf, lausn 5000 a.e./ml
leo pharma a/s* - heparinum natricum inn - stungulyf, lausn - 5000 a.e./ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
exemestan actavis filmuhúðuð tafla 25 mg
actavis group ptc ehf. - exemestanum inn - filmuhúðuð tafla - 25 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
elidel krem 1 %
viatris aps - pimecrolimusum inn - krem - 1 %
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
alizin vet. stungulyf, lausn 30 mg/ml
virbac s.a.* - aglepristonum inn - stungulyf, lausn - 30 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
aromasin húðuð tafla 25 mg
pfizer aps - exemestanum inn - húðuð tafla - 25 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
cefuroxim navamedic (cefuroxim villerton) stungulyfsstofn, lausn/dreifa 250 mg
navamedic asa - cefuroximum natríum - stungulyfsstofn, lausn/dreifa - 250 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
depo-medrol stungulyf, dreifa 40 mg/ml
pfizer aps - methylprednisolonum acetat - stungulyf, dreifa - 40 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
diprospan stungulyf, dreifa 5+2 mg/ml
n.v. organon* - betamethasonum dínatríumfosfat; betamethasonum díprópíónat - stungulyf, dreifa - 5+2 mg/ml